GUIDELINES FOR THE DOSAGE OF NEUROLEPTICS .1. CHLORPROMAZINE EQUIVALENTS OF ORALLY-ADMINISTERED NEUROLEPTICS

被引：176
作者：
REY, MJ
SCHULZ, P
COSTA, C
DICK, P
TISSOT, R
机构：
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1989年 / 4卷 / 02期
关键词：
D O I：
10.1097/00004850-198904000-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：95 / 104
页数：10
相关论文
共 41 条
[1]  
ABUZZAHAB FS, 1977, PSYCHOPHARMACOLOGY B, V13, P72
[2]  
APPLETON WS, 1982, J CLIN PSYCHIAT, V43, P12
[3]   WHAT IS THE BEST MAINTENANCE DOSE OF NEUROLEPTICS IN SCHIZOPHRENIA [J].
BALDESSARINI, RJ ;
DAVIS, JM .
PSYCHIATRY RESEARCH, 1980, 3 (02) :115-122
[4]   DRUG TREATMENT IN SCHIZOPHRENIA [J].
BAN, TA .
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1971, 16 (06) :473-485
[5]  
CASSANO G B, 1977, Psychopharmacology Bulletin, V13, P41
[6]  
CLAGHORN JL, 1983, PSYCHOPHARMACOL BULL, V19, P138
[7]   ANTIPSYCHOTIC MEDICATIONS - CLINICAL USE AND EFFECTIVENESS [J].
CORDOBA, OA .
HOSPITAL PRACTICE, 1981, 16 (12) :99-&
[8]   THE CLINICAL USE OF ANTIPSYCHOTIC MEDICATIONS [J].
COYLE, JT .
MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (05) :993-1009
[9]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[10]  
DAVIS J, 1983, NEUROLEPTICS NEUROCH
12345